NNC-55-0396-(free-base) and Neuralgia

NNC-55-0396-(free-base) has been researched along with Neuralgia* in 1 studies

Other Studies

1 other study(ies) available for NNC-55-0396-(free-base) and Neuralgia

Article	Year
The neuronal calcium ion channel activity of constrained analogues of MONIRO-1. Bioorganic & medicinal chemistry, 2020, 09-15, Volume: 28, Issue:18 Structural modifications of the neuronal calcium channel blocker MONIRO-1, including constraining the phenoxyaniline portion of the molecule and replacing the guanidinium functionality with tertiary amines, led to compounds with significantly improved affinities for the endogenously expressed Ca Topics: Anilides; Animals; Antineoplastic Agents; Benzodiazepines; Blood-Brain Barrier; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Neuralgia; Neurons; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction; Structure-Activity Relationship	2020

Article

Year

The neuronal calcium ion channel activity of constrained analogues of MONIRO-1.

Bioorganic & medicinal chemistry, 2020, 09-15, Volume: 28, Issue:18

Structural modifications of the neuronal calcium channel blocker MONIRO-1, including constraining the phenoxyaniline portion of the molecule and replacing the guanidinium functionality with tertiary amines, led to compounds with significantly improved affinities for the endogenously expressed Ca

Topics: Anilides; Animals; Antineoplastic Agents; Benzodiazepines; Blood-Brain Barrier; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Neuralgia; Neurons; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction; Structure-Activity Relationship

2020